Re-use of erlotinib in a patient using osimertinib after erlotinib, case report

Gursoy, P

Gursoy, P (通讯作者),Ege Univ, Sch Med, Tulay Aktas Oncol Hosp, TR-35100 Izmir, Turkey.

JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022; 28 (1): 211

Abstract

Introduction Most patients with non-small-cell lung cancer tumors that have epidermal growth factor receptor (EGFR) mutations have deletion mutations ......

Full Text Link